Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/9011| Title: | Outcomes Among Clopidogrel, Prasugrel, and Ticagrelor in ST-Elevation Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention From the TOTAL Trial | Authors: | Welsh, Robert C Sidhu, Robinder S Cairns, John A Lavi, Shahar Kedev Sasko Moreno, Raul Cantor, Warren J Stankovic, Goran Meeks, Brandi Yuan, Fei Džavík, Vladimír Jolly, Sanjit S |
Issue Date: | 2019 | Publisher: | Elsevier BV | Journal: | The Canadian journal of cardiology | Abstract: | Robust comparisons between oral P2Y12 inhibitors (clopidogrel, prasugrel, ticagrelor) in ST-elevation myocardial infarction (STEMI) patients who undergo primary percutaneous coronary intervention are lacking. We sought to evaluate outcomes on the basis of P2Y12 inhibitor therapy in patients from the Thrombectomy With PCI Versus PCI Alone in Patients With STEMI Undergoing Primary PCI (TOTAL) trial. | URI: | http://hdl.handle.net/20.500.12188/9011 | DOI: | 10.1016/j.cjca.2019.04.026 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.